Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 28, 2021, titled "Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC)".
Press Release Jan 28 2021
Filed with NSE · · 3 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 25 2021
- Press Release Jan 23 2021
- Press Release Jan 04 2021
- Press Release Dec 30 2020
- Press Release Dec 24 2020
Later from Zydus Lifesciences
- Press Release Feb 04 2021
- Press Release Feb 05 2021
- Press Release Feb 19 2021
- Press Release Feb 25 2021
- Press Release Mar 24 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences